Close

Cyclacel (CYCC) Reports Observation of PR, Stable Disease in Sapacitabine Phase 1, 2 in NSCLC Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. JBHT
2. UAL
3. SAGE
4. TSLA
5. TRV
6. PLD
7. OMC
8. IBKR
9. ITCI
10. ASML


Go back to Cyclacel (CYCC) Reports Observation of PR, Stable Disease in Sapacitabine Phase 1, 2 in NSCLC Patients